Drug-licensing anomalies and Parkinson's disease.
Bowman
C E
CE
D001058:Apomorphine / Q000592:standards* / Q000627:therapeutic use; D003024:Clozapine / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D006113:United Kingdom
D003024:Clozapine; D001058:Apomorphine